S00–T88: Injury, Poisoning and Certain Other Consequences of External Causes
Chapter 19 of ICD-10-CM 2027, 54,325 codes in 24 blocks.
Advertisements
Codes in this chapter
All codesBillable only54,325 results
- T44.3X4APoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter
- T44.3X4DPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter
- T44.3X4SPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela
- T44.3X5Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
- T44.3X5AAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
- T44.3X5DAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
- T44.3X5SAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
- T44.3X6Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
- T44.3X6AUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
- T44.3X6DUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
- T44.3X6SUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
- T44.4Poisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists
- T44.4XPoisoning by, adverse effect of and underdosing of predominantly alpha-adrenoreceptor agonists
- T44.4X1Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional)
- T44.4X1APoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter
- T44.4X1DPoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
- T44.4X1SPoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela
- T44.4X2Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm
- T44.4X2APoisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter
- T44.4X2DPoisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter
- T44.4X2SPoisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela
- T44.4X3Poisoning by predominantly alpha-adrenoreceptor agonists, assault
- T44.4X3APoisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter
- T44.4X3DPoisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter
- T44.4X3SPoisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela
- T44.4X4Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined
- T44.4X4APoisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter
- T44.4X4DPoisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter
- T44.4X4SPoisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela
- T44.4X5Adverse effect of predominantly alpha-adrenoreceptor agonists
- T44.4X5AAdverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
- T44.4X5DAdverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
- T44.4X5SAdverse effect of predominantly alpha-adrenoreceptor agonists, sequela
- T44.4X6Underdosing of predominantly alpha-adrenoreceptor agonists
- T44.4X6AUnderdosing of predominantly alpha-adrenoreceptor agonists, initial encounter
- T44.4X6DUnderdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter
- T44.4X6SUnderdosing of predominantly alpha-adrenoreceptor agonists, sequela
- T44.5Poisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists
- T44.5XPoisoning by, adverse effect of and underdosing of predominantly beta-adrenoreceptor agonists
- T44.5X1Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional)
- T44.5X1APoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter
- T44.5X1DPoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
- T44.5X1SPoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela
- T44.5X2Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm
- T44.5X2APoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter
- T44.5X2DPoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter
- T44.5X2SPoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela
- T44.5X3Poisoning by predominantly beta-adrenoreceptor agonists, assault
- T44.5X3APoisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter
- T44.5X3DPoisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter